Ocugen To Participate In Fireside Chat At Cantor Global Healthcare Conference Sept. 28 at 8 a.m. EDT
Ocugen, Inc. (NASDAQ:OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, today announced